This is the first of two stories on monitoring the safety of new drugs — read the second here

W

hen a new remedy for rheumatoid arthritis arrived, ads called it a “unique” breakthrough that would “transform expectations” for patients and doctors. “If I knew then what I know now about rheumatoid arthritis, I would have been more proactive,” said one young woman, pictured happily kayaking.

This is a STAT Plus article and is only available to STAT Plus subscribers.
To read the full story, subscribe to STAT Plus or log in to your account.
Good news: your first 30 days are on us.

Leave a Comment

Please enter your name.
Please enter a comment.

  • Bread, specifically na’an, gave me arthritis. Took 6 months of abstaining for my finger joints to feel normal again.

  • Well researched indeed. But at the risk of labelled a Roche stooge, I find this too one-sided and biased. For e.g., you could have delved deeper to see what percentage of Actemra patients who suffered these severe AEs were recipients of Humira/Enbrel in previous lines of therapy? May be they carried the risks flagged for those drugs? And may be that is why if Actemra is no worse than Humira/Enbrel in heart AEs or pulmonary AEs, that shows that they are not increasing the threats?

    Obviously the caveats of statistical analysis notwithstanding, it will be a “definitive” proof of your claims if you show how many of the SAEs/deaths happened when patients took Actemra in first-line, compared to later lines of therapy. You have to consider the disease progression by the time patients end up getting Actemra.

  • Hello I have been on this medication every 4 weeks for 3 years reading this I am worried I do get palpitations I have a enlarged liver but the side effects are not addressed I am in uk

  • Excellent research and reporting, thank you. Please consider a similar series monitoring the safety of medical and dental devices, which receive even less scrutiny by the FDA than pharmaceuticals.

  • We feel we have a Fix/prophylactic for Alzheimer’s Please GOOGLE Jack William Schultz, presented there.
    Our most recent profound finding: Alzheimer’s patients that have reached a state/stage of Severe Agitation (requiring multiple caregivers 24/7) better than 80% of those patients STOP those symptoms in 5 days or less. No longer needing multiple caregivers 24/7.
    Pharma not happy with a cost effective drug to address this and other issues noted in my patents.
    What do you suggest to avoid bankrupting Social Security,Medicare and Medicaid in the next 15 years?
    404-697-5353 404-803-5409

    • Have you tried marketing/studies in the usual manner. You are selling!
      If you truly have magic drug, go through proper channels. Can you cite publications? Thx

Recommended Stories

Sign up for our biotech newsletter, The Readout

A guide to what’s new in biotech — delivered straight to your inbox every weekday morning.